Antitumour necrosis factor-α therapy for hidradenitis suppurativa : results from a national cohort study between 2000 and 2013
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:174 |
|---|---|
| Enthalten in: |
The British journal of dermatology - 174(2016), 3 vom: 28. März, Seite 667-70 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sbidian, E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adalimumab |
|---|
| Anmerkungen: |
Date Completed 03.01.2017 Date Revised 04.01.2017 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/bjd.14199 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM253098319 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM253098319 | ||
| 003 | DE-627 | ||
| 005 | 20231224165514.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjd.14199 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0843.xml |
| 035 | |a (DE-627)NLM253098319 | ||
| 035 | |a (NLM)26406350 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sbidian, E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antitumour necrosis factor-α therapy for hidradenitis suppurativa |b results from a national cohort study between 2000 and 2013 |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.01.2017 | ||
| 500 | |a Date Revised 04.01.2017 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 7 | |a Dermatologic Agents |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
| 650 | 7 | |a Infliximab |2 NLM | |
| 650 | 7 | |a B72HH48FLU |2 NLM | |
| 650 | 7 | |a Adalimumab |2 NLM | |
| 650 | 7 | |a FYS6T7F842 |2 NLM | |
| 650 | 7 | |a Etanercept |2 NLM | |
| 650 | 7 | |a OP401G7OJC |2 NLM | |
| 700 | 1 | |a Hotz, C |e verfasserin |4 aut | |
| 700 | 1 | |a Seneschal, J |e verfasserin |4 aut | |
| 700 | 1 | |a Maruani, A |e verfasserin |4 aut | |
| 700 | 1 | |a Amelot, F |e verfasserin |4 aut | |
| 700 | 1 | |a Aubin, F |e verfasserin |4 aut | |
| 700 | 1 | |a Paul, C |e verfasserin |4 aut | |
| 700 | 1 | |a Beylot Barry, M |e verfasserin |4 aut | |
| 700 | 1 | |a Humbert, P |e verfasserin |4 aut | |
| 700 | 1 | |a Dupuy, A |e verfasserin |4 aut | |
| 700 | 1 | |a Caux, F |e verfasserin |4 aut | |
| 700 | 1 | |a Dupin, N |e verfasserin |4 aut | |
| 700 | 1 | |a Modiano, P |e verfasserin |4 aut | |
| 700 | 1 | |a Lepesant, P |e verfasserin |4 aut | |
| 700 | 1 | |a Ingen-Housz-Oro, S |e verfasserin |4 aut | |
| 700 | 1 | |a Mahé, E |e verfasserin |4 aut | |
| 700 | 1 | |a Bachelez, H |e verfasserin |4 aut | |
| 700 | 1 | |a Chosidow, O |e verfasserin |4 aut | |
| 700 | 1 | |a Wolkenstein, P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The British journal of dermatology |d 1951 |g 174(2016), 3 vom: 28. März, Seite 667-70 |w (DE-627)NLM000000361 |x 1365-2133 |7 nnns |
| 773 | 1 | 8 | |g volume:174 |g year:2016 |g number:3 |g day:28 |g month:03 |g pages:667-70 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjd.14199 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 174 |j 2016 |e 3 |b 28 |c 03 |h 667-70 | ||